Seagen
SGEN
#563
Rank
HK$337.15 B
Marketcap
HK$1,787
Share price
-0.07%
Change (1 day)
69.31%
Change (1 year)

Market capitalization of Seagen (SGEN)

Last known market cap: HK$337.15 Billion

On February 9, 2024 Seagen had a market cap of HK$337.15 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Seagen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$335.03 B-0.6%
2023HK$337.04 B80.79%
2022HK$186.42 B-15.43%
2021HK$220.43 B-9.3%
2020HK$243.02 B58.79%
2019HK$153.05 B115.24%
2018HK$71.10 B18.2%
2017HK$60.16 B3.86%
2016HK$57.92 B19.22%
2015HK$48.58 B57.26%
2014HK$30.89 B-18.54%
2013HK$37.92 B76.41%
2012HK$21.49 B43.99%
2011HK$14.93 B26.31%
2010HK$11.82 B49.23%
2009HK$7.92 B33.93%
2008HK$5.91 B-1.46%
2007HK$6.00 B183.73%
2006HK$2.11 B36.4%
2005HK$1.55 B-27.2%
2004HK$2.13 B0.01%
2003HK$2.13 B187.08%
2002HK$0.74 B-43.07%
2001HK$1.30 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.174 T 248.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$3.079 T 813.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$206.17 B-38.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$875.55 B 159.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$814.75 B 141.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
HK$1.65 B-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
HK$68.15 B-79.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$12.77 B-96.21%๐Ÿ‡บ๐Ÿ‡ธ USA